
|
Number 12 -
DECEMBER 2006 COLORECTAL CANCER - RISK FACTORS, STAGING, FOLLOW-UP AND SCREENING. Lorenzi M, Lorenzi B, Vernillo R. Serum ferritin in colorectal cancer patients and its prognostic evaluation. Int J Biol Markers. 2006 Oct-Dec;21(4):235-41.
Lopez-Kostner F, Fullerton
DA, Kronberg U, Soto G, Zuniga A, Argandona J, Miranda
V, Pinto E. [Screening
colonoscopy among first degree relatives of patients
with colorectal carcinoma] Terhaar sive Droste JS, Craanen ME, Kolkman JJ, Mulder CJ. Dutch endoscopic capacity in the era of colorectal cancer screening. Neth J Med. 2006 Nov;64(10):371-3. Loss J, Eichhorn C, Nagel E. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer). Z Gastroenterol. 2006 Nov;44(11):1127-34. Kaneko I, Tanaka S, Oka S, Kawamura T, Hiyama T, Ito M, Yoshihara M, Shimamoto F, Chayama K. Lymphatic Vessel Density at the Site of Deepest Penetration as a Predictor of Lymph Node Metastasis in Submucosal Colorectal Cancer. Dis Colon Rectum. 2006 Nov 17; Ganeshan A, Upponi S, Uberoi R, D'Costa H, Picking C, Bungay H. Minimal-preparation CT colon in detection of colonic cancer, the Oxford experience. Age Ageing. 2006 Nov 17; Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, Wolmark N. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst. 2006 Nov 15;98(22):1647-54.
McGory ML,
Shekelle PG, Ko CY.
Development of quality indicators for patients
undergoing colorectal cancer surgery. Korner H, Soreide K, Stokkeland PJ, Soreide JA. Diagnostic Accuracy of Serum-Carcinoembryonic Antigen in Recurrent Colorectal Cancer: A Receiver Operating Characteristic Curve Analysis. Ann Surg Oncol. 2006 Nov 14; Koch M, Kienle P, Logan E, Antolovic D, Galindo L, Schmitz-Winnenthal FH, Schmidt J, Herfarth C, Weitz J. Detection of Disseminated Tumor Cells in Liver Biopsies of Colorectal Cancer Patients Is not Associated with a Worse Prognosis. Ann Surg Oncol. 2006 Nov 11;
Gross CP,
McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti
ME.
The effect of age and chronic illness on life expectancy
after a diagnosis of colorectal cancer: implications for
screening. Ferrante JM, Ohman-Strickland P, Hudson SV, Hahn KA, Scott JG, Crabtree BF. Colorectal cancer screening among obese versus non-obese patients in primary care practices. Cancer Detect Prev. 2006;30(5):459-65. Lee YJ, Lee HR, Nam CM, Hwang UK, Jee SH. White blood cell count and the risk of colon cancer. Yonsei Med J. 2006 Oct 31;47(5):646-56. Stapley S, Peters TJ, Sharp D, Hamilton W. The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records. Br J Cancer. 2006 Nov 20;95(10):1321-5. Larsson SC, Giovannucci E, Wolk A. Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer. 2006 Nov 6;95(9):1277-9. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC Jr; ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006 Nov 20;24(33):5313-27.
Holt AD, Kim
JT, Murrell Z, Huynh R, Stamos MJ, Kumar RR.
The role of carcinoembryonic antigen as a predictor of
the need for preoperative computed tomography in colon
cancer patients.
Allen-Mersh
TG, McCullough TK, Patel H, Wharton RQ, Glover C, Jonas
SK.
Role of circulating tumour cells in predicting
recurrence after excision of primary colorectal
carcinoma. Schoofs N, Deviere J, Van Gossum A. PillCam colon capsule endoscopy compared with colonoscopy for colorectal tumor diagnosis: a prospective pilot study. Endoscopy. 2006 Oct;38(10):971-7.
Eliakim R,
Fireman Z, Gralnek IM, Yassin K, Waterman M, Kopelman Y,
Lachter J, Koslowsky B, Adler SN.
Evaluation of the PillCam Colon capsule in the detection
of colonic pathology: results of the first multicenter,
prospective, comparative study.
Pezzoli A, Matarese V,
Rubini M, Simoni M, Caravelli GC, Stockbrugger R, Cifala
V, Boccia S, Feo C, Simone L, Trevisani L, Liboni A,
Gullini S.
Colorectal cancer screening: Results of a 5-year program
in asymptomatic subjects at increased risk. Colebatch A, Hitchins M, Williams R, Meagher A, Hawkins NJ, Ward RL. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer. 2006 Nov 6;95(9):1239-43. O'Dwyer PJ. The present and future of angiogenesis-directed treatments of colorectal cancer. Oncologist. 2006 Oct;11(9):992-8. Review. Valera VA, Walter BA, Yokoyama N, Koyama Y, Iiai T, Okamoto H, Hatakeyama K. Prognostic Groups in Colorectal Carcinoma Patients Based on Tumor Cell Proliferation and Classification and Regression Tree (CART) Survival Analysis. Ann Surg Oncol. 2007 Jan;14(1):34-40.
Zitt M, Zitt
M, Muller HM, Dinnewitzer AJ, Schwendinger V, Goebel G,
De Vries A, Amberger A, Weiss H, Margreiter R, Ofner D,
Oberwalder M.
Disseminated tumor cells in peripheral blood: a novel
marker for therapy response in locally advanced rectal
cancer patients undergoing preoperative chemoradiation. Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006 Sep 27;296(12):1507-17. Review. Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006 Nov 1;107(9):2152-9. Messerini L, Cianchi F, Cortesini C, Comin CE. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol. 2006 Oct;37(10):1259-67. Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer. 2006 Oct 1;107(7):1624-33. Zauber NP, Sabbath-Solitare M, Marotta S, Perera LP, Bishop DT. Adequacy of colonoscopic biopsy specimens for molecular analysis: a comparative study with colectomy tissue. Diagn Mol Pathol. 2006 Sep;15(3):162-8.
Tjalsma H,
Scholler-Guinard M, Lasonder E, Ruers TJ, Willems HL,
Swinkels DW.
Profiling the humoral immune response in colon cancer
patients: diagnostic antigens from Streptococcus bovis. |